Description
The National Institutes of Health (NIH) intends to award a sole source firm-fixed-price contract to Oxford Nanopore Technologies Inc. for the procurement of PromethION 2 Integrated Instrument. The instrument will be used to perform long read genomic DNA sequencing of patient samples to detect DNA mutations, DNA structural abnormalities, and DNA methylation. The Department of Laboratory Medicine serves as the clinical laboratory of the NIH Clinical Center, providing laboratory support for patient care and research protocols, and performing research and training in disciplines of Clinical Hematological Pathology.
* The PromethION 2 Integrated Instrument is used for long read genomic DNA sequencing.
* The instrument will be used to detect DNA mutations, DNA structural abnormalities, and DNA methylation.
* The Department of Laboratory Medicine provides laboratory support for patient care and research protocols.
* The contract is being awarded on a sole source basis due to Oxford Nanopore being the original instrument manufacturer and sole vendor for instruments of these kinds of tests.
Attached files
The solicitation documents live at the source — open the bid source above to download them.